COMPANY

Icogenex

HQ: Seattle, WA source · icogenex.com ↗ · West Coast

Location: Seattle, WA · source · Oct 15, 2026

Profile checked Oct 10, 2026

30NIH grants

NIH awards 30

Annual award amounts. Total $6.8M.

Jul 20, 2009 NIH award 3R43NS064648-01S1 FY2009: $9,335 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. Substrate Based Proteolytic Inhibitors for source ↗
Jan 5, 2009 NIH award 1R43NS064648-01 FY2009: $361,935 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. Substrate Based Proteolytic Inhibitors for source ↗
Feb 4, 2005 NIH award 1R43AG024043-01A1 FY2005: $369,148 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. Alzheimer's Therapeutic Derived from a N source ↗
Dec 25, 2003 NIH award 5R44AI051136-03 FY2004: $504,143 awarded for that fiscal year; activity R44 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. Novel agonists and antogonists of chemokin source ↗
2003 NIH award 1R43AG022283-01 FY2003: $369,888 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. Effector of APP to Lower Amount of beta-Am source ↗
2003 NIH award 2R44AI051136-02 FY2003: $489,461 awarded for that fiscal year; activity R44 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. Novel agonists and antogonists of chemokin source ↗
2003 NIH award 5R01HL066000-04 FY2003: $175,232 awarded for that fiscal year; activity R01 (OTHER_NIH); PI GUNAJE, JAYARAMA B; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. CONTROL OF IL-6 BY THROMBIN IN LUNG F source ↗
Mar 8, 2002 NIH award 1R43AI051136-01 FY2002: $95,223 awarded for that fiscal year; activity R43 (SBIR); PI DEVOS, THEO; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. Novel agonists and antagonists of chemokine recept source ↗
Nov 23, 2001 NIH award 5R01HL066000-03 FY2002: $195,140 awarded for that fiscal year; activity R01 (OTHER_NIH); PI GUNAJE, JAYARAMA B; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. CONTROL OF IL-6 BY THROMBIN IN LUNG F source ↗
Jan 8, 2001 NIH award 5R01HL066000-02 FY2001: $189,455 awarded for that fiscal year; activity R01 (OTHER_NIH); PI GUNAJE, JAYARAMA B; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. CONTROL OF IL-6 BY THROMBIN IN LUNG F source ↗
Aug 25, 2000 NIH award 1R43DK058421-01 FY2000: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI SWANK, RICHARD A; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. NOVEL PEPTIDE INDUCERS OF GAMMA GLOBIN EXPRE source ↗
Jun 6, 2000 NIH award 5R43CA081958-02 FY2000: $172,431 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. AFFINITY AND TRANSCRIPTASE TECHNOLOGIES source ↗
Feb 10, 2000 NIH award 1R01HL066000-01 FY2000: $146,821 awarded for that fiscal year; activity R01 (OTHER_NIH); PI GUNAJE, JAYARAMA B; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. CONTROL OF IL-6 BY THROMBIN IN LUNG F source ↗
Sep 10, 1999 NIH award 1R43AI044512-01 FY1999: $150,174 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. DEVELOPMENT OF AN ANTI-SEPSIS THERAPEUTIC source ↗
Aug 19, 1999 NIH award 5R44CA081777-03 FY1999: $492,970 awarded for that fiscal year; activity R44 (SBIR); PI RAO, DONALD; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. LEPTIN AND HEMATOPOIESIS source ↗
Aug 16, 1999 NIH award 5R44CA082078-03 FY1999: $385,355 awarded for that fiscal year; activity R44 (SBIR); PI DEVOS, THEO; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. HEMATOPOIETIC MAST CELL REGULATORY FACTORS source ↗
May 5, 1999 NIH award 3R21CA076935-02S1 FY1999: $1,454 awarded for that fiscal year; activity R21 (OTHER_NIH); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. FULL LENGTH REPRESENTATIONAL CDNA LIB source ↗
Mar 19, 1999 NIH award 1R43CA081958-01 FY1999: $172,430 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. AFFINITY AND TRANSCRIPTASE TECHNOLOGIES source ↗
Sep 29, 1998 NIH award 9R44CA082078-02 FY1998: $374,774 awarded for that fiscal year; activity R44 (SBIR); PI DEVOS, THEO; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. HEMATOPOIETIC MAST CELL REGULATORY FACTORS source ↗
Sep 28, 1998 NIH award 9R44CA081777-02 FY1998: $478,611 awarded for that fiscal year; activity R44 (SBIR); PI RAO, DONALD; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. LEPTIN AND HEMATOPOIESIS source ↗
Sep 11, 1998 NIH award 5R21CA076935-02 FY1998: $131,861 awarded for that fiscal year; activity R21 (OTHER_NIH); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. FULL LENGTH REPRESENTATIONAL CDNA LIB source ↗
Sep 11, 1998 NIH award 1R21CA076935-01 FY1997: $128,020 awarded for that fiscal year; activity R21 (OTHER_NIH); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. FULL LENGTH REPRESENTATIONAL CDNA LIB source ↗
Feb 2, 1998 NIH award 5R44HL055886-03 FY1998: $384,108 awarded for that fiscal year; activity R44 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. HEMATOPOIETIC STEM CELL RENEWAL FACTOR source ↗
Sep 26, 1997 NIH award 1R43HL058415-01 FY1997: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI RAO, DONALD; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. LEPTIN AND HEMATOPOIESIS source ↗
Feb 27, 1997 NIH award 1R43DK052244-01 FY1997: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. HEMATOPOIETIC MAST CELL REGULATORY FACTORS source ↗
Jan 21, 1997 NIH award 2R44HL055886-02 FY1997: $365,892 awarded for that fiscal year; activity R44 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. HEMATOPOIETIC STEM CELL RENEWAL FACTOR source ↗
Aug 26, 1996 NIH award 1R43DK051919-01 FY1996: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI RAO, DONALD; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. ATYPICAL NEUROPEPTIDE Y RECEPTOR OF HYPOTHALAMUS source ↗
May 30, 1996 NIH award 1R43HL056980-01 FY1996: $91,163 awarded for that fiscal year; activity R43 (SBIR); PI DAY, JOSEPH R; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. CLONING THE DEFECT IN TANGIER DISEASE--HDL RECEP source ↗
Mar 21, 1996 NIH award 1R43DK050917-01 FY1996: $95,588 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. CLONING OF RECEPTOR FOR THE OBESE GENE PROD source ↗
Mar 18, 1996 NIH award 1R43HL055886-01 FY1996: $100,000 awarded for that fiscal year; activity R43 (SBIR); PI HAGEN, FREDERICK S; recipient as written: ICOGENEX CORPORATION, SEATTLE, WA. CLONING THE HEMATOPOIETIC STEM CELL RENEWA source ↗